2020 Best of Breast
Avatar

Treatment of 55 y/o Woman with T2, Node Negative TNBC - Developing Adrenal Insufficiency After Nab-Paclitaxel + Atezolizumab, Management of Endocrinopathies & New Agents in TNBC

By 2020 Best of Breast FEATURING Kevin Kalinsky, Salila Kurra, Sunil Badve, Jane Meisel, Lee Schwartzberg
By 2020 Best of Breast FEATURING Kevin Kalinsky, Salila Kurra, Sunil Badve, Jane Meisel, Lee Schwartzberg
261 views
March 2, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
14:16
Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
04:28
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …

Feat. S. Tolaney
07:50
Oncology Data Advisor

ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, &a…

Feat. K. Kalinsky
22:34
Dana-Farber Cancer Institute

What's New in Breast Cancer?

Feat. S. Tolaney
50:59
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Early Stage Breast Cancer"

Feat. S. Tolaney, H. Rugo
17:35
Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…

Feat. P. Tarantino
30:46
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo
24:36
ESMO 2022 Conference Coverage

ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates

Feat. H. Rugo, J. O'Shaughnessy
12:21
Insights from 2023 SABCS

SABCS 2023 Insights: "How to Treat TNBC"

Feat. P. Sharma
20:42
Total Health

2022 Updates in TNBC

Feat. I. Schlam
03:37
Insights from 2023 SABCS

SABCS 2023 Summary: "Is There a Role for Purely Adjuvant IO in …

Feat. S. Tolaney, H. Rugo
14:01
Insights from 2023 SABCS

SABCS 2023 Summary: "Is There a Role for IO in Early Stage High…

Feat. S. Tolaney, H. Rugo
07:49
UChicago Medicine

Antibody Drug Conjugates: Overview and Background of a Revolution in…

Feat. H. Rugo
14:19
Muhammad Nisar

Aromatase Inhibitors and Fracture Prevention - Do New Guidelines Wor…

17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
35:14
OncoAlert

Advanced TNBC Updates

Feat. H. Rugo
26:30
Insights from 2023 SABCS

SABCS 2023 Summary: "HER2+ BC Highlights From KATHERINE & H…

Feat. S. Tolaney, H. Rugo
11:10
Dana-Farber Cancer Institute

Antibody Drug Conjugates in Breast Cancer

Feat. S. Tolaney
09:51
Cleveland Clinic Taussig Cancer Institute

Mitigation of Cytopenia and Diarrhea Associated With Sacituzumab Gov…

Feat. E. Roesch